Description of a human Bocavirus recombinant strain in the Americas Leia mais sobre Description of a human Bocavirus recombinant strain in the Americas
SARS-CoV-2 variant N.9 identified in Rio de Janeiro, Brazil Leia mais sobre SARS-CoV-2 variant N.9 identified in Rio de Janeiro, Brazil
Homologous equivalence study of immunogenicity after third dose of Covid-19 vaccine (recombinant) with an interval of six months after the second dose, comparing the interval of eight and 12 weeks between the first two doses Leia mais sobre Homologous equivalence study of immunogenicity after third dose of Covid-19 vaccine (recombinant) with an interval of six months after the second dose, comparing the interval of eight and 12 weeks between the first two doses
